Meg Duroux
Overview
Explore the profile of Meg Duroux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
1187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gudbergsson J, Christensen E, Kostrikov S, Moos T, Duroux M, Kjaer A, et al.
Mol Neurobiol
. 2020 Jul;
57(9):3943-3955.
PMID: 32632605
Glioblastoma (GBM) is the most frequent and devastating primary tumor of the central nervous system with a median survival of 12 to 15 months after diagnosis. GBM is highly difficult...
2.
Gudbergsson J, Duroux M
Eur J Cell Biol
. 2019 Sep;
98(5-8):151044.
PMID: 31543278
Cripto-1 is a protein participating in tissue orientation during embryogenesis but has also been implicated in a wide variety of cancers, such as colon, lung and breast cancer. Cripto-1 plays...
3.
Gudbergsson J, Duroux M
J Cell Biochem
. 2019 Jul;
121(1):545-556.
PMID: 31310365
Cripto-1 is a protein expressed during embryonal development and has been linked to several malignant processes in cancer. Since the discovery of cripto-1 in the late 1980s, it has become...
4.
Gudbergsson J, Kostrikov S, Johnsen K, Fliedner F, Stolberg C, Humle N, et al.
Exp Cell Res
. 2019 Mar;
379(1):73-82.
PMID: 30922921
Glioblastoma multiforme (GBM) is the most common and malignant type of primary brain tumor and is characterized by its sudden onset and invasive growth into the brain parenchyma. The invasive...
5.
Vinterhoj H, Stensballe A, Duroux M, Gazerani P
J Proteomics
. 2018 Mar;
190:27-34.
PMID: 29581063
Satellite glial cells (SGCs) in sensory ganglia contribute to the pathogenesis of chronic pain, potentially through mediating extracellular or paracrine signaling. Recently, extracellular vesicles (EVs) in the form of exosomes...
6.
Johnsen K, Gudbergsson J, Duroux M, Moos T, Andresen T, Simonsen J
J Control Release
. 2017 Nov;
269:10-14.
PMID: 29126999
The field of extracellular vesicle (EV)-based drug delivery systems has evolved significantly through the recent years, and numerous studies suggest that these endogenous nanoparticles can function as efficient drug delivery...
7.
Johnsen K, Gudbergsson J, Skov M, Christiansen G, Gurevich L, Moos T, et al.
Cytotechnology
. 2016 Feb;
68(5):2125-38.
PMID: 26856590
In the recent years, the possibility of utilizing extracellular vesicles for drug delivery purposes has been investigated in various models, suggesting that these vesicles may have such potential. In addition...
8.
Gudbergsson J, Johnsen K, Skov M, Duroux M
Cytotechnology
. 2015 Oct;
68(4):579-92.
PMID: 26433593
The potential therapeutic utility of extracellular vesicles (EVs) has spawned an interest into a scalable production, where the quantity and purity of EV samples is sufficient for clinical applications. EVs...
9.
Klauzinska M, Bertolette D, Tippireddy S, Strizzi L, Gray P, Gonzales M, et al.
Connect Tissue Res
. 2015 Sep;
56(5):364-80.
PMID: 26327334
Cripto-1 (CR-1) is a multifunctional embryonic protein that is re-expressed during inflammation, wound repair, and malignant transformation. CR-1 can function either as a tethered co-receptor or shed as a free...
10.
Poulsen J, Warwick R, Duroux M, Hanani M, Gazerani P
Exp Cell Res
. 2015 May;
336(1):94-9.
PMID: 25999145
Communications between satellite glial cells and neighboring neurons within sensory ganglia may contribute to neuropathic and inflammatory pain. To elucidate the role of satellite glial cells in chemotherapy-induced pain, we...